Alzheimer’s Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Alzheimer’s Disease Clinical Trials Market Report Overview
In total there were 2,605 clinical trials conducted on alzheimer’s disease as of March 2023. The Alzheimer’s Disease clinical trial market research report provides an overview of Alzheimer’s Disease clinical trials scenario. The report provides top-line data relating to the clinical trials on Alzheimer’s Disease. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Key Regions | · North America
· Europe · Asia-Pacific · Middle East & Africa · South & Central America |
Key Countries | · The US
· China · The UK · Germany · France · Spain |
Key Sponsor Types | · Institution
· Company · Government |
Leading Sponsors | · Pfizer Inc
· Johnson & Johnson · Eli Lilly and Co · Eisai Co Ltd · F. Hoffmann-La Roche Ltd · Novartis AG |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Alzheimer’s Disease Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Alzheimer Disease clinical trial market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America. Most of the clinical trials were conducted in North America.
In the country wise analysis, the US has the highest number of Alzheimer’s Disease clinical trials, as of March 2023. Canada has highest average patient enrollment of Alzheimer’s Disease as of March 2023.
As on March 2023, there were more than 300 clinical trials in progress and more than 1,700 trials were completed. Many trials were terminated / suspended or withdrawn due to the lack of efficacy, safety, and lack of accrual of subjects.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Mexico has the highest proportion of Alzheimer’s Disease to central nervous system clinical trials as of March 2023.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the UK has the highest proportion of Alzheimer’s Disease to central nervous system clinical trials as of March 2023.
Alzheimer’s Disease Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Alzheimer’s Disease Clinical Trials Market, Download A Free Report Sample
Alzheimer’s Disease Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Alzheimer’s Disease clinical trials market are institution, company, and the government. Out of them, the company sponsor type dominates the market.
Alzheimer’s Disease Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
Buy The Full Report for More Sponsor Type Insights into the Alzheimer’s Disease Clinical Trials Market, Download A Free Report Sample
Alzheimer’s Disease Clinical Trials Market - Competitive Landscape
The leading sponsors in the Alzheimer’s Disease clinical trials market are Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Eisai Co Ltd, F. Hoffmann-La Roche Ltd, and Novartis AG among others. As of March 2023, Pfizer Inc sponsored the highest number of Alzheimer’s Disease trials.
Alzheimer’s Disease Clinical Trials Market Analysis by Sponsors, 2023 (%)
Buy the Full Report to know More About The Leading Players in the Alzheimer’s Disease Clinical Trials Market, Download A Free Report Sample
Segments Covered in the Report
Alzheimer’s Disease Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
Alzheimer’s Disease Clinical Trials Country Outlook (2023)
- The US
- China
- The UK
- Germany
- France
- Spain
Alzheimer’s Disease Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies regarding investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Johnson & Johnson
Eli Lilly and Co
Eisai Co Ltd
F. Hoffmann-La Roche Ltd
Novartis AG
AbbVie Inc
AstraZeneca Plc
Merck & Co Inc
The Lundbeck Foundation
Table of Contents
Table
Figures
Frequently asked questions
-
Which was the leading regional segment in the Alzheimer’s Disease clinical trials market in 2023?
North America was the leading regional segment in the Alzheimer’s Disease clinical trials market in 2023.
-
Which country dominated the Alzheimer’s Disease clinical trials market in 2023?
The US dominated the Alzheimer’s Disease clinical trials market in 2023.
-
Which was the leading sponsor type in the Alzheimer’s Disease clinical trials market in 2023?
The company sponsor type led the Alzheimer’s Disease clinical trials market in 2023.
-
Who are the leading sponsors in the Alzheimer’s Disease clinical trials market?
The leading sponsors in the Alzheimer’s Disease clinical trials market are Pfizer Inc, Johnson & Johnson, Eli Lilly and Co, Eisai Co Ltd, F. Hoffmann-La Roche Ltd, and Novartis AG.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.